Abstract
The authors evaluated the variations in sex hormones due to the menstrual cycle (and oral contraceptives) for their effect on tear physiology. Subjects were 18 females taking oral contraceptives or their age-matched controls (no medication) aged 21–33 years. Symptoms of ocular discomfort (visual analog scale), tear film structure (TearScope), noninvasive tear thinning time (HirCal grid), evaporation rate (ServoMed evaporimeter), osmolality (Nanolitre Osmometer), tear turnover rate, tear volume (Fluorotron Master), and tear protein levels (HPLC) were measured around day two (D2), actually day 1–4 and day 19 (D19) actually day 18–21 of the cycle. No significant differences were found for any tear parameters between D2 and D19 for either pill users or controls alone, or in the comparison of pill users with controls. No effect on tear physiology was found for serum hormone changes induced by oral contraceptive use or by normal cyclic variations in healthy young females.—Thomas J. Liesegang
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
